diabetes Articles
-
The role of anthropometric indices in predicting comorbidities of obesity in a rural Egyptian population
Obesity is associated with higher prevalence of type2 diabetes and hypertension. Objectives were determining prevalence of obesity, type2 diabetes and hypertension in a rural village. This cross sectional study included 1,000 male and female ≥ 20 years. Blood pressure, anthropometry, fasting and 2 hr post-prandial glucose were determined. Results showed 29.7% overweight and 45.6% obese. Visceral ...
-
Diabetes knowledge and attitudes towards prevention and health promotion: qualitative study in Sharjah, United Arab Emirates
This study explored the knowledge of and attitudes towards diabetes, diabetes prevention and management, and health promotion of patients attending medical centres in Sharjah, United Arab Emirates. Forty-one patients participated in an in depth interview. Common themes were drawn upon and reported. The understanding of the causation of diabetes varied, including genetics, stress and lifestyle. ...
-
A Break Through in Diabetes Testing and Monitoring: Exclusive Interview with Asad Zaidi CEO of Epinex Diagnostics, Inc.
Not a day goes by without any news on diabetes. It is one the world’s most debilitating chronic disease. The number of people with diabetes is estimated to be over 500 Million, and it is increasing at an alarming rate of 9% every year. Diabetes is also rising more rapidly in the middle and low-income countries. It is one of the leading causes of death in the world. More than 100 million ...
-
Type 1 Diabetes Treatment Market is anticipated to progress at a CAGR of 7.8% by 2032
The global Type 1 Diabetes Treatment market size was estimated to be US$ 7.02 Billion in 2022 and is geared to grow at a CAGR of 7.8% between 2023 to 2032.The Type 1 Diabetes Treatment market report is a combination of qualitative and quantitative data that highlights significant industry changes, obstacles that businesses and the competition must overcome, as well as new possibilities and trends ...
By insightSLICE
-
Glooko Named a Leader by Independent Research Firm in Diabetes Digital Therapeutics for Healthcare Payers
At Glooko, we believe being named a leader in CB Insights’ Diabetes Digital Therapeutics For Healthcare Payers — Execution & Market Strength Positioning (ESP) Vendor Matrix validates what our customers have been saying about our commitment to providing innovative digital health tools for chronic conditions like diabetes. Glooko was among the select companies that CB Insights ...
By Glooko, Inc.
-
Project - Sublingual Dual Incretin Inhibitor (GLP-1/GIP)
Biolingus explores the development of a sublingual dual incretin inhibitor. BioLingus will position these products in the “epidemic” markets of obesity and type II diabetes : More than 400 MM people suffer from diabetes today. The global type 2 diabetes market is expected to grow to $58.7 billion by 2025, with an annual growth rate of 6.5%, according to research and consulting ...
By BioLingus AG
-
Rapid Point-of-Care Test for Determination of C-Peptide Levels
Abstract C-peptide is co-secreted with insulin and is not subject to hepatic clearance and thus reflects functional β-cell mass. Assessment of C-peptide levels can identify individuals at risk for or with type 1 diabetes with residual β-cell function in whom β cell-sparing interventions can be evaluated, and can aid in distinguishing type 2 diabetes from Latent Autoimmune Diabetes ...
-
Impact of feeding flaxseed oil on delaying the development of osteoporosis in ovariectomised diabetic rats
This work is aimed to study the effect of diabetes on bone health and to evaluate the impact of feeding flaxseed oil on delaying osteoporosis. About 70 female albino rats were included; 30 were ovariectomised (ovx). Experimental diabetes was induced. Rats were classified in groups as control, sham, diabetic, diabetic received flaxseed oil in the diet, ovx, ovx-diabetic and ovx-diabetic received ...
-
Effects of tobacco (smoking and snuffing) in type 2 diabetic patients
The present study aimed to evaluate the effects of tobacco on different biochemical and physical parameters in type 2 diabetic subjects from Dera Ismail Khan, NWFP, Pakistan. A total of 100 chronic type 2 diabetic patients of different age and sex with no tobacco addiction and with tobacco addiction were requested to volunteer their complete biodata on a given Performa. Blood biochemical ...
-
Suppressive effect of low-dose X-irradiation on type I diabetes non-obese diabetic (NOD) mice
We examined the effect of X-irradiation (0, 0.25, 0.5 or 1.0 Gy) on the onset of the type I diabetes (insulin dependent diabetes mellitus) in non-obese diabetic (NOD) mice. NOD mice are characterised by a progressive loss of insulin-producing β-cells in the pancreas by autoimmune mechanisms. The destruction of β-cells is known to be due to apoptosis induced by oxidative stress caused by ROS. In ...
-
Diabetes and COVID-19
As we celebrate World Diabetes Day its theme this year is more poignant than ever. Focusing on ‘the nurse and diabetes’, in a year which has seen us being hit by a COVID pandemic and our health service being challenged more than ever, it seems a fitting tribute to celebrate and shine a light on nurses in this way. And as the management of diabetes continues to be an important part of ...
-
Management of Type 2 Diabetesusing non-invasive CGM
There is compelling evidence suggesting Type 2 diabetes may be managed by use of a Continuous Gucose Monitor (CGM) on non consecutive days, leading to clinically significant outcomes. Invasive CGMs are generally designed for wear periods of up to 14 consecutive days: with the associated cost. The additional costs are not justified where significant clinical outcomes can potentially be achieved ...
-
Glucose biosensor based on platinum nanowires: a clinical study
We describe the process of modification of the platinum (Pt) nanowire surface and subsequent immobilisation of enzyme glucose oxidase (GOx) on Pt nanowires (PtNWs) for direct glucose measurement. A cyclic voltammetry technique was used to measure electrochemical oxidation between GOx and glucose. PtNW arrays were first fabricated and then functionalised with cysteamine, which in turn acted as a ...
-
Project - Sublingual Exenatide
Liraglutide and exenatide are both belonging to the class of diabetes products called GLP-1 analogues. The GLP-1 analogues have established themselves in the past years as one of the superior drug classes for treatment of diabetes type II in terms of blood glucose lowering and weight loss. Because of the latter, they are being used more and more also in the treatment of obesity. Until now, both ...
By BioLingus AG
-
UK Imaging Diabetes Study Seeing Diabetes Clearly - Case Study
Prospective observational cohort study with clinical outcomes data collection. Recruiting adult patients with type 2 diabetes (T2DM) and diabetic retinopathy (DR), who lack history of cardiovascular ...
By Perspectum
-
Diabetic Foot Ulcer - Case study
Patient History Patient is a 40-year-old female with a history of type 2 diabetes. Patient presented to the Emergency Room with a diabetic foot ulcer and infection. The surgeon took the patient to the OR for debridement, drained the infection, and started antibiotics. The patient was treated with advanced modalities that included NPWT and a bioengineered skin substitute. Primary Diagnosis ...
-
Treatment of a Pressure Ulcer using CDO Therapy - Case study
Christine Salcher, DPM Sherman, Texas and Amyee McAlister, Healthline Patient: 50-year-old Caucasian female with a pressure ulcer that has progressively gotten larger, deeper, more malodorous, fibrotic, and necrotic Comorbidities: Diabetes, diabetic retinopathy & peripheral neuropathy Age of Wound: 90 days Days on Service: 55 days Outcome: Goals met. Wound healed. High patient ...
By EO2 Concepts
-
Project - Sublingual IL2 (BL SLIT I)
The aim of this project is to develop low dose IL-2 for treatment of early onset juvenile Type I diabetes. Low dose injectable IL-2 in animal models has been shown to restore the balance between regulatory and effector T cells and, in this way, can help to reverse autoimmunity and the development of type I diabetes. Looking ahead, we anticipate that having a suitable oral formulation of IL-2 to ...
By BioLingus AG
-
The role of nanotechnology in diabetes treatment: current and future perspectives
Diabetes is a chronic disease that currently affects approximately 8% of the US population, and that number is expected to increase significantly by the year 2030. It is imperative that effective monitoring and treatment options be available to patients. Nanotechnology is a focal point in diabetes research, where nanoparticles in particular are showing great promise in improving the treatment and ...
-
Diabetes faces iPeak technology
DiabetOmics DiabetOmics®, Inc. is a global, commercial stage medical diagnostics company pioneering innovative, non-invasive point-of-care tests that are especially useful in alleviating the substantial economic and public health burden of maternal health and diabetes. They operate in USA and India. The primary area of focus is the diabetes market with products related to the detection ...
By IUL S.A.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you